中文
| Catalogue |
| Recommend Products |
Company News
- OGT Makes Market-leading NGS Coverage and Expertise more Accessible 6/14/2019
- OGT to Open New Cytocell Facility in Cambridge, UK 2/27/2019
- OGT further Expands Global Direct Sales and Support into Asia-Pacific Region 11/9/2018
- OGT launches Enhanced SureSeq™ Interpret NGS Analysis Software 8/8/2018
- OGT Expands Direct Sales and Support Infrastructure in Europe 7/6/2018
- OGT expands custom NGS cancer panel content and readies 6/13/2018
- OGT enhances customer experience with new Cytocell website 3/8/2018
- OGT the Molecular Genetics Company to be acquired by Sysmex Corporation 6/1/2017
- OGT Expands Cytocell Sarcoma FISH Probe Range 12/16/2016
- OGT Releases Targeted NGS Panel to Study SNV and CNV in Familial Hypercholesterolemia 12/9/2016
- OGT Announces Commercial and Financial Highlights for FY 2016 11/23/2016
- Customer Input Drives Expansion of OGT’s Cytocell Aquarius® Haematology FISH Probe Ran... 10/12/2016
- OGT Simplifies Detection of Important Cancer Gene Variants 9/27/2016
- OGT Expands Cytocell FISH Probe Portfolio for Lung Cancers 9/14/2016
- Leading Experts Reveal How Exon-Focused Microarrays are Advancing Genetic Syndrome Researc... 7/15/2016
- OGT launches 9 new high-intensity, low-background Cytocell Aquarius® FISH probes 6/23/2016
- OGT Enhances NGS Results from FFPE Samples 6/12/2016
- OGT Develops New FISH Probes in ‘outstanding’ Innovate UK Project 4/14/2016
- OGT Expands Leading Constitutional Array Range — Enabling Exon-level CNV and LOH Detection 3/17/2016
- OGT Licenses SNP Probe Technology to Baylor Miraca Genetics Laboratories 11/13/2015